Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4 studies found for:    "methodist hospital" | Open Studies | "Anemia" | United States, Texas | Houston
Show Display Options
Rank Status Study
1 Recruiting A Phase 1 Safety Study of SANGUINATE™ In Patients With Acute Severe Anemia.
Conditions: Anemia;   Anoxia
Intervention: Drug: SANGUINATE™
2 Not yet recruiting Optimizing Cord Blood and Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)
Condition: Severe Aplastic Anemia
Interventions: Drug: Antithymocyte Globulin;   Drug: Fludarabine;   Drug: Cyclophosphamide;   Radiation: Total Body Irradiation (TBI);   Procedure: UCB HSCT;   Procedure: Haplo HSCT;   Drug: Tacrolimus;   Drug: Mycophenolate mofetil (MMF);   Drug: G-CSF
3 Not yet recruiting STRIDE Biorepository
Condition: Anemia, Sickle Cell
Intervention: Procedure: Blood draw
4 Not yet recruiting Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503)
Condition: Sickle Cell Disease
Interventions: Drug: Busulfan;   Drug: Fludarabine;   Drug: r-ATG;   Procedure: Bone Marrow Transplant;   Drug: Tacrolimus;   Drug: Methotrexate;   Procedure: Standard of Care

Indicates status has not been verified in more than two years